IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen ...

Meanwhile, Amgen’s offer price is at an approximately 20% premium to Horizon’s closing price of €92.48 ($97.29) on Friday 9 th December. Californian biotech Amgen’s own market value is ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report) and Align Tech (ALGN – ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...

Shares of Amgen Inc. AMGN rose 1.62% to $285.98 Friday, on what proved to be an all-around great trading session for the ...

Amgen has gotten caught up in the broader market decline, but its business is unscathed. Its obesity drug sales are about to boom, making the stock look like a buy.

Shares in Horizon Therapeutics have been in sharp decline after reports emerged that the US financial regulator is preparing a challenge to its $28 billion takeover by Amgen. The stock fell 18% in ...

The SPE-DEX 4790 Automated Extraction System is a fully automated SPE system designed to rapidly process environmental water samples using solid phase extraction for trace level analysis of ...